Form D · Pharmaceuticals
EMMAUS MEDICAL INC
Torrance, CA · CIK 0001271340
Offering snapshot reported May 27, 2011 · SEC filing
- Reported sold
- $1.15M Offering amount: $1.15M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2011 | Initial | $1,153,750 | No comparison | 21 | SEC filing |
| Jan 18, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-160475
Source: Form D, filed May 27, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Willis C. Lee | Director, Executive |
| Henry Mc Kinnel, Jr. | Director |
| Yasushi Nagasaki | Executive |
| Yutaka Niihara | Director, Executive |
| Lan T. Tran | Executive |
| Douglas Wilmore | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
20725 S. Western Ave., Suite 136
Torrance, CA, 90501-1884
Torrance, CA, 90501-1884